APA

Breistøl K., Hendriks H. R., Berger D. P., Langdon S. P., Fiebig H. H. & Fodstad O. (19990125). The antitumour activity of the prodrug N-L-leucyl-doxorubicin and its parent compound doxorubicin in human tumour xenografts. : European journal of cancer (Oxford, England : 1990).

Chicago

Breistøl K, Hendriks H R, Berger D P, Langdon S P, Fiebig H H and Fodstad O. 19990125. The antitumour activity of the prodrug N-L-leucyl-doxorubicin and its parent compound doxorubicin in human tumour xenografts. : European journal of cancer (Oxford, England : 1990).

Harvard

Breistøl K., Hendriks H. R., Berger D. P., Langdon S. P., Fiebig H. H. and Fodstad O. (19990125). The antitumour activity of the prodrug N-L-leucyl-doxorubicin and its parent compound doxorubicin in human tumour xenografts. : European journal of cancer (Oxford, England : 1990).

MLA

Breistøl K, Hendriks H R, Berger D P, Langdon S P, Fiebig H H and Fodstad O. The antitumour activity of the prodrug N-L-leucyl-doxorubicin and its parent compound doxorubicin in human tumour xenografts. : European journal of cancer (Oxford, England : 1990). 19990125.